RYMAN HEALTHCARE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.42 NZD | -0.67% |
|
-1.78% | -25.08% |
| Feb. 19 | Ryman Healthcare Lowers Fiscal Year 2024 Underlying Profit Guidance; Shares Fall 8% | MT |
| 2023 | Ryman Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| Sales 2024 * | 653M 384M | Sales 2025 * | 711M 419M | Capitalization | 3.03B 1.78B |
|---|---|---|---|---|---|
| Net income 2024 * | 347M 204M | Net income 2025 * | 398M 234M | EV / Sales 2024 * | 8.48 x |
| Net Debt 2024 * | 2.51B 1.48B | Net Debt 2025 * | 2.53B 1.49B | EV / Sales 2025 * | 7.82 x |
| P/E ratio 2024 * |
8.07
x | P/E ratio 2025 * |
7.56
x | Employees | 7,200 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.79% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ryman Healthcare Limited
More press releases
More news
| 1 day | -0.67% | ||
| 1 week | -1.78% | ||
| Current month | -2.86% | ||
| 1 month | -3.70% | ||
| 3 months | -24.44% | ||
| 6 months | -25.71% | ||
| Current year | -25.08% |
1 week
4.41
4.52
1 month
4.344.65
Current year
4.346.02
1 year
4.346.99
3 years
4.3415.85
5 years
4.3417.20
10 years
4.3417.20
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Umbers
CEO | Chief Executive Officer | 57 | 21-10-24 |
| Director of Finance/CFO | - | Nov. 14 | |
Rick Davies
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Geoffrey Cumming
BRD | Director/Board Member | - | 18-05-31 |
James Miller
BRD | Director/Board Member | - | 23-05-31 |
Kate Munnings
BRD | Director/Board Member | - | Oct. 31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.10% | 18 M€ | +1.40% | - | |
| 0.02% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 4.42 | -0.67% | 414,804 |
| 24-04-17 | 4.45 | +0.23% | 260,012 |
| 24-04-16 | 4.44 | -1.33% | 488,222 |
| 24-04-15 | 4.5 | 0.00% | 313,439 |
| 24-04-12 | 4.5 | 0.00% | 443,297 |
End-of-day quote New Zealand S.E., April 17, 2024
More quotes
Ryman Healthcare Limited is a vertically integrated retirement-living and aged-care developer, owner and operator. The Company develops, owns and operates integrated retirement villages, rest homes, and hospitals for the elderly within New Zealand and Australia. It provides a range of retirement-living options, including independent apartments and townhouses and assisted living in serviced apartments. Its aged-care offering includes rest homes, hospitals and dementia care. The Company's assisted living offers a range of services, including scheduled transport services and outings, village management and administration, maintaining and operating the community amenities, and gardening and ground maintenance and others. Its one, two and three-bedroom apartments and townhouses offer a neutral color palette. It also offers musical entertainment, fashion shows, arts and crafts, and regular outings. It owns and operates 38 villages across New Zealand and seven in Victoria, Australia.
Calendar
2024-05-26
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.42
NZD
Average target price
7.452
NZD
Spread / Average Target
+68.60%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.08% | 1.79B | |
| -12.12% | 87.46B | |
| +9.72% | 78.56B | |
| +10.85% | 29.37B | |
| -12.25% | 16.78B | |
| -5.52% | 16.01B | |
| -8.68% | 13.98B | |
| +0.58% | 12.31B | |
| -30.35% | 12.07B | |
| +20.38% | 11.06B |
- Stock Market
- Equities
- RYM Stock
